New Hampshire Senate Bill SB616

New Hampshire 2026 Regular Session

• Introduced: 11/25/25
• Refer: 11/25/25
• Report Pass: 2/5/26
• Report Pass: 3/5/26

Caption

Relative to reporting requirements under the right to try act.

Impact

The implementation of SB616 is set to have significant repercussions on how healthcare facilities operate in the state. The Department of Health and Human Services is required to compile an annual aggregated report based on the submitted data and to adopt rules related to the data collection process. The mandatory reporting could enhance the understanding of the use of experimental treatments in the state, potentially leading to improved healthcare policies. However, it imposes an administrative burden on healthcare providers, prompting concerns regarding compliance costs and operational adjustments necessary for implementation.

Summary

Senate Bill 616 (SB616) amends the Right to Try Act by introducing new reporting requirements for healthcare providers and facilities involved in administering care under this act. The bill mandates that healthcare providers report certain types of information to the facilities where treatment is provided. This data includes the type of illness the patient suffers from, the patient's state residency at the time of consultation and treatment commencement, the licensing authorities for the provider, and whether the treatment was covered by the patient’s insurance. Reports will be submitted to the Department of Health and Human Services (DHHS) without identifying any personal information about the patients or providers involved.

Contention

One of the notable points of contention surrounding SB616 relates to the administrative requirements and potential fines for noncompliance. The bill stipulates a daily administrative fine of $100 for facilities that fail to adhere to the reporting requirements. This punitive approach raises concerns among healthcare providers about the feasibility of compliance, especially for smaller facilities that may lack the resources to manage additional bureaucratic responsibilities. Furthermore, while the intent of improving data collection is acknowledged by many stakeholders, some argue that the added restrictions might hinder patient access to care under the Right to Try Act.